497510·Stock-Sector-Healthcare
ACE Global Big Pharma
Introduction
The ACE Global Big Pharma ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Solactive Global Big Pharma Index PR
Investment Points
An ETF focused on investing in 15 major global pharmaceutical companies.
Benchmark Index
Solactive Global Big Pharma Index PR
Benchmark Index Description
An index comprising the top 15 global big pharma companies with blockbuster drugs, selected based on market capitalization and projected pharmaceutical sales growth rates.
Issuer
Korea Investment Management Co.
Brand
ACE
Total Fee
0.3
Listing Date
2024-11-19
International Securities Code
KR7497510008
Market Information
Market Capitalization
8,684,000,000KRW
Transaction Amount
17,800,680KRW
Trading Volume
1,639
Shares Outstanding
800,000
NAV
10,893
52-Week High
10,875KRW
52-Week Low
9,900KRW